128 related articles for article (PubMed ID: 8986274)
1. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
Tambor ES; Rimer BK; Strigo TS
Am J Med Genet; 1997 Jan; 68(1):43-9. PubMed ID: 8986274
[TBL] [Abstract][Full Text] [Related]
2. Interest in BRCA1/2 testing in a primary care population.
Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
[TBL] [Abstract][Full Text] [Related]
3. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
4. Intention to pursue genetic testing for breast cancer among women due for screening mammography.
Gwyn K; Vernon SW; Conoley PM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):96-102. PubMed ID: 12582018
[TBL] [Abstract][Full Text] [Related]
5. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
8. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
[TBL] [Abstract][Full Text] [Related]
9. Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
Ramirez AG; Aparicio-Ting FE; de Majors SS; Miller AR
Ethn Dis; 2006; 16(2):398-403. PubMed ID: 17682241
[TBL] [Abstract][Full Text] [Related]
10. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
MacNew HG; Rudolph R; Brower ST; Beck AN; Meister EA
Breast J; 2010; 16(2):189-92. PubMed ID: 20030654
[TBL] [Abstract][Full Text] [Related]
11. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; LubiĆski J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
12. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
13. Interest in genetic testing among first-degree relatives of breast cancer patients.
Lerman C; Seay J; Balshem A; Audrain J
Am J Med Genet; 1995 Jul; 57(3):385-92. PubMed ID: 7677139
[TBL] [Abstract][Full Text] [Related]
14. Women's knowledge and attitudes about genetic testing for breast cancer susceptibility.
Ludman EJ; Curry SJ; Hoffman E; Taplin S
Eff Clin Pract; 1999; 2(4):158-62. PubMed ID: 10539540
[TBL] [Abstract][Full Text] [Related]
15. Another round in the mammography controversy.
Meissner HI; Rimer BK; Davis WW; Eisner EJ; Siegler IC
J Womens Health (Larchmt); 2003 Apr; 12(3):261-76. PubMed ID: 12804357
[TBL] [Abstract][Full Text] [Related]
16. Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.
Bruno M; Digennaro M; Tommasi S; Stea B; Danese T; Schittulli F; Paradiso A
Eur J Cancer Care (Engl); 2010 May; 19(3):360-8. PubMed ID: 19912305
[TBL] [Abstract][Full Text] [Related]
17. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
18. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
[TBL] [Abstract][Full Text] [Related]
19. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]